PL372760A1 - Jednostki dawkowania progestagenu - Google Patents

Jednostki dawkowania progestagenu

Info

Publication number: PL372760A1
Authority: PL; Poland
Prior art keywords: progestagenic; dosage units; dosage; units; progestagenic dosage
Prior art date: 2002-05-29

Application number

PL03372760A

Other languages

English (en)

Inventor

Haan Pieter De

Original Assignee

Akzo Nobel N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-29

Filing date

2003-05-22

Publication date

2005-08-08

2003-05-22 Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.

2005-08-08 Publication of PL372760A1 publication Critical patent/PL372760A1/pl

Links

230000000757 progestagenic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Gynecology & Obstetrics (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL03372760A 2002-05-29 2003-05-22 Jednostki dawkowania progestagenu PL372760A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02077097		2002-05-29

Publications (1)

Publication Number	Publication Date
PL372760A1 true PL372760A1 (pl)	2005-08-08

Family

ID=29558382

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL03372760A PL372760A1 (pl)	2002-05-29	2003-05-22	Jednostki dawkowania progestagenu

Country Status (20)

Country	Link
US (1)	US20050181040A1 (pl)
EP (1)	EP1511495A1 (pl)
JP (1)	JP2005529929A (pl)
KR (1)	KR20050004869A (pl)
CN (1)	CN1655795A (pl)
AR (1)	AR040113A1 (pl)
AU (1)	AU2003238082A1 (pl)
BR (1)	BR0311209A (pl)
CA (1)	CA2487279A1 (pl)
HR (1)	HRP20041102A2 (pl)
IL (1)	IL165085A0 (pl)
IS (1)	IS7538A (pl)
MX (1)	MXPA04011796A (pl)
NO (1)	NO20044900L (pl)
PE (1)	PE20040040A1 (pl)
PL (1)	PL372760A1 (pl)
RU (1)	RU2004138599A (pl)
TW (1)	TW200403075A (pl)
WO (1)	WO2003099291A1 (pl)
ZA (1)	ZA200409110B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4756153B2 (ja) *	2004-08-27	2011-08-24	富士製薬工業株式会社	低成分含量の錠剤の製造方法
WO2009101182A1 (en) *	2008-02-15	2009-08-20	N.V. Organon	Use of etonogestrel for benign prostate hyperplasia (bph).
WO2017000081A1 (zh) *	2015-06-30	2017-01-05	上海交通大学	Etonogestrel在制备抗前列腺癌产品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2613223B1 (fr) *	1987-04-03	1991-09-13	Biogalenique Laboratoires	Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation
IE71203B1 (en) *	1990-12-13	1997-02-12	Akzo Nv	Low estrogen oral contraceptives
IE71202B1 (en) *	1990-12-17	1997-02-12	Akzo Nv	Progestagen-only contraceptive
US5395627A (en) *	1992-09-04	1995-03-07	Akzo N.V.	Pharmaceutical granulate
IL113816A (en) *	1994-06-08	1998-12-06	Akzo Nobel Nv	Pharmaceutical compositions containing desogestrel their preparation and use
US5633011A (en) *	1994-08-04	1997-05-27	Alza Corporation	Progesterone replacement therapy
MX9702162A (es) *	1994-09-22	1997-06-28	Akzo Nobel Nv	Procedimiento para hacer unidades de dosis mediante granulacion en humedo.
US5595759A (en) *	1994-11-10	1997-01-21	Alza Corporation	Process for providing therapeutic composition
US6395300B1 (en) *	1999-05-27	2002-05-28	Acusphere, Inc.	Porous drug matrices and methods of manufacture thereof
KR100342943B1 (ko) *	1999-08-04	2002-07-02	민경윤	비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물

2003
- 2003-05-19 TW TW092113497A patent/TW200403075A/zh unknown
- 2003-05-22 KR KR10-2004-7019057A patent/KR20050004869A/ko not_active Withdrawn
- 2003-05-22 MX MXPA04011796A patent/MXPA04011796A/es not_active Application Discontinuation
- 2003-05-22 BR BR0311209-8A patent/BR0311209A/pt not_active Application Discontinuation
- 2003-05-22 HR HRP20041102 patent/HRP20041102A2/xx not_active Application Discontinuation
- 2003-05-22 AU AU2003238082A patent/AU2003238082A1/en not_active Abandoned
- 2003-05-22 US US10/515,670 patent/US20050181040A1/en not_active Abandoned
- 2003-05-22 CA CA002487279A patent/CA2487279A1/en not_active Abandoned
- 2003-05-22 EP EP03735714A patent/EP1511495A1/en not_active Withdrawn
- 2003-05-22 RU RU2004138599/15A patent/RU2004138599A/ru not_active Application Discontinuation
- 2003-05-22 JP JP2004506815A patent/JP2005529929A/ja not_active Withdrawn
- 2003-05-22 CN CNA038120925A patent/CN1655795A/zh active Pending
- 2003-05-22 PL PL03372760A patent/PL372760A1/pl not_active Application Discontinuation
- 2003-05-22 WO PCT/EP2003/050189 patent/WO2003099291A1/en not_active Ceased
- 2003-05-27 PE PE2003000509A patent/PE20040040A1/es not_active Application Discontinuation
- 2003-05-27 AR ARP030101840A patent/AR040113A1/es unknown
2004
- 2004-11-08 IL IL16508504A patent/IL165085A0/xx unknown
- 2004-11-10 NO NO20044900A patent/NO20044900L/no not_active Application Discontinuation
- 2004-11-10 ZA ZA200409110A patent/ZA200409110B/en unknown
- 2004-11-18 IS IS7538A patent/IS7538A/is unknown

Also Published As

Publication number	Publication date
BR0311209A (pt)	2005-03-15
AR040113A1 (es)	2005-03-16
US20050181040A1 (en)	2005-08-18
EP1511495A1 (en)	2005-03-09
ZA200409110B (en)	2005-05-18
CN1655795A (zh)	2005-08-17
MXPA04011796A (es)	2005-03-31
AU2003238082A1 (en)	2003-12-12
IL165085A0 (en)	2005-12-18
WO2003099291A1 (en)	2003-12-04
RU2004138599A (ru)	2005-06-10
JP2005529929A (ja)	2005-10-06
CA2487279A1 (en)	2003-12-04
HRP20041102A2 (en)	2004-12-31
PE20040040A1 (es)	2004-01-31
IS7538A (is)	2004-11-18
KR20050004869A (ko)	2005-01-12
TW200403075A (en)	2004-03-01
NO20044900L (no)	2005-02-25

Legal Events

Date	Code	Title	Description
2011-01-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL174343A0 (en)	2009-02-11	Delayed released dosage forms
AU2003291103A8 (en)	2004-06-15	Pharmaceutical composition
IL164547A0 (en)	2005-12-18	Pharmaceutical composition
IL165878A0 (en)	2006-01-15	Pharmaceutical composition
GB0206505D0 (en)	2002-05-01	Pharmaceutical combination
AU2003291758A8 (en)	2004-06-07	Waxy matrix dosage forms
PL373409A1 (pl)	2005-08-22	Kombinacja farmaceutyczna
GB0201520D0 (en)	2002-03-13	Pharmaceutical uses
HRP20041102A2 (en)	2004-12-31	Progestagenic dosage units
PL355453A1 (pl)	2004-02-23	Środek farmaceutyczny
HK1071693A (en)	2005-07-29	Progestagenic dosage units
GB0217703D0 (en)	2002-09-11	Pharmaceutical composition
GB0315019D0 (en)	2003-07-30	Dosage form
EP1547593A4 (en)	2009-12-23	MEDICINAL COMPOSITION
GB0220451D0 (en)	2002-10-09	Pharmaceutical use
GB0210240D0 (en)	2002-06-12	Pharmaceutical combination
GB0211377D0 (en)	2002-06-26	Medicament
GB0214885D0 (en)	2002-08-07	Medicament
GB0224680D0 (en)	2002-12-04	Pharmaceutical
AU148728S (en)	2002-08-05	Tablet
AU148730S (en)	2002-08-05	Tablet
AU148729S (en)	2002-08-05	Tablet
GB0213267D0 (en)	2002-07-24	Pharmaceutical composition
GB0210238D0 (en)	2002-06-12	Pharmaceutical composition
GB0225042D0 (en)	2002-12-04	Pharmaceutical composition